ES2571828T3 - Formulaciones veterinarias que no contienen productos de origen animal - Google Patents

Formulaciones veterinarias que no contienen productos de origen animal

Info

Publication number
ES2571828T3
ES2571828T3 ES03788474T ES03788474T ES2571828T3 ES 2571828 T3 ES2571828 T3 ES 2571828T3 ES 03788474 T ES03788474 T ES 03788474T ES 03788474 T ES03788474 T ES 03788474T ES 2571828 T3 ES2571828 T3 ES 2571828T3
Authority
ES
Spain
Prior art keywords
group
starch
cellulose
sodium
humectant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES03788474T
Other languages
English (en)
Inventor
Douglas Cleverly
Michelle Hagenbuch
Jun Chen
Abul Azad
James Muhitch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Animal Health USA Inc
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Application granted granted Critical
Publication of ES2571828T3 publication Critical patent/ES2571828T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Abstract

Formulación veterinaria masticable adecuada para utilizar en el tratamiento de perros, cuya formulación veterinaria masticable no contiene productos de origen animal, y que comprende: - una cantidad eficaz de al menos un agente farmacéutico; - al menos una carga; - al menos un disgregante; - al menos un producto de origen no animal que contiene sabor o un sabor derivado de una fuente no animal; - al menos un aglutinante; - al menos un humectante; - al menos un disolvente de granulación; y - opcionalmente, al menos un antioxidante, al menos un modificador de pH, al menos un agente tensioactivo, al menos un conservante, al menos un lubricante o al menos un colorante; y en la que - la carga se selecciona del grupo que consiste en proteína de soja, mazorca de maíz y harina de gluten de maíz; - el disgregante se selecciona del grupo que consiste en glicolato de almidón sódico, crospovidona, croscarmelosa sódica, almidón, celulosa microcristalina, ácido algínico, veegum, bentonita y almidón pregelatinizado; - el aglutinante se selecciona del grupo que consiste en polivinil pirrolidona, povidona, almidón, almidón pregelatinizado, metilcelulosa, hidroxipropil celulosa, carboximetil celulosa sódica, etilcelulosa, alginato sódico, tragacanto y goma arábiga; - el humectante se selecciona del grupo que consiste en propilenglicol, glicerina y polietilenglicol 400; - el disolvente de granulación es agua o una solución acuosa de sorbitol; y en la que el agente farmacéutico es un compuesto seleccionado del grupo que consiste en un agente antiparasitario, ácido nodulispórico, estrógenos, progestinas, andrógenos, imidacloprid, fenilpirazoles e inhibidores de la bomba de protones.
ES03788474T 2002-08-16 2003-08-14 Formulaciones veterinarias que no contienen productos de origen animal Expired - Lifetime ES2571828T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/222,559 US20040037869A1 (en) 2002-08-16 2002-08-16 Non-animal product containing veterinary formulations
PCT/US2003/025448 WO2004016252A1 (en) 2002-08-16 2003-08-14 Non-animal product containing veterinary formulations

Publications (1)

Publication Number Publication Date
ES2571828T3 true ES2571828T3 (es) 2016-05-27

Family

ID=31886626

Family Applications (1)

Application Number Title Priority Date Filing Date
ES03788474T Expired - Lifetime ES2571828T3 (es) 2002-08-16 2003-08-14 Formulaciones veterinarias que no contienen productos de origen animal

Country Status (17)

Country Link
US (1) US20040037869A1 (es)
EP (1) EP1539116B1 (es)
JP (1) JP2006502140A (es)
KR (1) KR20050053619A (es)
CN (1) CN1681482B (es)
AU (2) AU2003258224A1 (es)
BR (1) BR0313528B1 (es)
CR (2) CR7742A (es)
CY (1) CY1117477T1 (es)
DK (1) DK1539116T3 (es)
ES (1) ES2571828T3 (es)
HK (1) HK1071705A1 (es)
HU (1) HUE029071T2 (es)
MX (1) MXPA05001825A (es)
NZ (1) NZ538333A (es)
SI (1) SI1539116T1 (es)
WO (1) WO2004016252A1 (es)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US20040077703A1 (en) * 2002-10-02 2004-04-22 Soll Mark D. Nodulisporic acid derivative spot-on formulations for combating parasites
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
MXPA05010659A (es) * 2003-04-04 2005-12-12 Merial Ltd Formulaciones veterinarias antihelminticas topicas.
TWI366442B (en) 2003-07-30 2012-06-21 Novartis Ag Palatable ductile chewable veterinary composition
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
US20050234119A1 (en) * 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
KR100593794B1 (ko) 2004-07-27 2006-06-30 대원제약주식회사 멜록시캄을 포함하는 경구투여용 조성물
US7318920B2 (en) * 2004-09-27 2008-01-15 Ez-Med Company Low water activity nutritional product having beneficial microbial and high oil content
CN101277701A (zh) * 2005-09-30 2008-10-01 贝林格尔·英格海姆维特梅迪卡有限公司 含有美洛昔康的药物制剂
US20070128251A1 (en) * 2005-12-07 2007-06-07 Piedmont Pharmaceuticals, Inc. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US7955632B2 (en) 2005-12-07 2011-06-07 Bayer B.V. Process for manufacturing chewable dosage forms for drug delivery and products thereof
US20080160067A1 (en) * 2006-09-07 2008-07-03 Albert Boeckh Novel soft chewable, tablet, and long-acting injectable veterinary antibiotic formulations
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation
CL2008000596A1 (es) * 2007-03-01 2008-09-05 Glaxo Group Ltd Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
WO2008134819A1 (en) * 2007-05-07 2008-11-13 Jurox Pty Ltd Improved dosage form and process
WO2009023014A1 (en) * 2007-08-13 2009-02-19 Alpharma, Inc. Emamectin compositions and methods
US20110118243A1 (en) * 2008-03-20 2011-05-19 Lynn Chambers Anti-inflammatory drug delivery system
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
DE102008047910A1 (de) 2008-09-19 2010-03-25 Molkerei Meggle Wasserburg Gmbh & Co. Kg Tablettierhilfsstoff auf Laktose- und Cellulosebasis
US9820977B2 (en) * 2008-10-03 2017-11-21 Bayer Healthcare Llc Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
KR20110097840A (ko) * 2008-11-17 2011-08-31 바스프 에스이 전분 함유 과립 제제
ES2436716T3 (es) 2008-11-25 2014-01-03 Boehringer Ingelheim Vetmedica Gmbh Pimobendan para uso en el tratamiento de la cardiomiopatía hipertrófica en gatos
TW201041510A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
TW201041509A (en) * 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity
TW201041507A (en) 2009-04-30 2010-12-01 Dow Agrosciences Llc Pesticide compositions exhibiting enhanced activity and methods for preparing same
WO2010132286A1 (en) * 2009-05-12 2010-11-18 Wyeth Llc Orally administered tablet formulation of an antianxiolytic compound
DK2488145T3 (da) * 2009-10-12 2024-07-22 Boehringer Ingelheim Vetmedica Gmbh Beholdere til sammensætninger omfattende meloxicam
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
UA108641C2 (uk) * 2010-04-02 2015-05-25 Паразитицидна композиція, яка містить чотири активних агенти, та спосіб її застосування
AU2016247183B2 (en) * 2010-04-02 2018-03-29 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising multiple active agents, methods and uses thereof
AU2015202084B2 (en) * 2010-04-02 2016-07-28 Boehringer Ingelheim Animal Health USA Inc. Parasiticidal compositions comprising multiple active agents, methods and uses thereof
MX2012012196A (es) * 2010-04-22 2013-02-27 Genesis Lab Inc Composiciones y metodos para el control de las moscas de arena y otros insectos que succionan la sangre.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
ES2806256T3 (es) * 2010-10-12 2021-02-17 Bayer Ip Gmbh Productos masticables blandos no basados en almidón
DK2755498T3 (en) 2011-09-15 2018-05-22 Friulchem Spa COMPOSITION FOR ORAL ADMINISTRATION FOR ANIMALS AND PROCEDURE FOR OBTAINING
MD20170008A2 (ro) 2012-02-06 2017-07-31 Merial Inc. Compoziţii veterinare antiparazitare orale cu conţinut de agenţi activi cu acţiune sistemică, metode şi aplicări ale acestora
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
EP2833866B1 (en) 2012-04-04 2018-11-21 Intervet International B.V. Soft chewable pharmaceutical products
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
CA2906295C (en) 2013-03-15 2019-01-22 Argenta Manufacturing Limited Chewable formulation
EP3014269A4 (en) * 2013-06-27 2017-02-22 Ruprecht Keller Methods and compositions for marking urine samples to identify source
KR102455648B1 (ko) 2013-07-19 2022-10-19 베링거잉겔하임베트메디카게엠베하 보존된 에테르화된 사이클로덱스트린 유도체 함유 액체 수성 약제학적 조성물
BR122019024673B1 (pt) 2013-12-04 2023-04-11 Boehringer Ingelheim Vetmedica Gmbh Composições farmacêuticas aprimoradas de pimobendan
EP2957909B1 (en) 2014-06-18 2019-01-30 Ruprecht Keller Method for identifying of a biological sample of a mammal and composition for use in this method
CN104026419B (zh) * 2014-07-01 2016-01-20 大连赛姆生物工程技术有限公司 一种犬自主采食型植物源复合药效营养品及其制备方法
US10721930B2 (en) 2014-12-23 2020-07-28 Cap Innovet, Inc. Dermal compositions
KR101688093B1 (ko) * 2015-02-03 2016-12-20 (주)이엘티사이언스 가축용 이버멕틴 경구용 정제 복합 조성물 및 그 제조방법
US9808010B2 (en) * 2015-07-06 2017-11-07 Virbac Corporation Chewable composition
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
SG11201809772QA (en) 2016-05-12 2018-12-28 Bayer Animal Health Gmbh Method for the production of molded bodies for administration to animals
US10137111B2 (en) 2016-08-11 2018-11-27 Adamis Pharmaceuticals Corporation Drug compositions comprising an anti-parasitic and proton pump inhibitor
KR101921727B1 (ko) * 2016-12-28 2018-11-23 주식회사 제네웰 실리콘 수지 조성물, 이의 제조방법 및 이를 포함하는 흉터 치료제
GB201701417D0 (en) 2017-01-27 2017-03-15 Mars Inc Pet food
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
RU2686462C1 (ru) * 2018-04-06 2019-04-26 федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный аграрный университет" Антиоксидантный противовоспалительный препарат для животных
BR112021016480A2 (pt) 2019-02-20 2021-10-13 Zoetis Services Llc Formulações palatáveis
WO2021001043A1 (de) 2019-07-04 2021-01-07 Monika Wetzke Ortsunabhängige einnahmekontrolle
JP2022546240A (ja) * 2019-09-06 2022-11-04 エランコ・ユーエス・インコーポレイテッド 口当たりの良い顆粒状の獣医学的組成物
TW202122077A (zh) * 2019-09-06 2021-06-16 美商拜耳保健責任有限公司 適口軟咀嚼物
EP3878436A1 (en) 2020-03-09 2021-09-15 Bayer Animal Health GmbH Soft chewable formed body for the administration to animals
EP4146011A1 (en) * 2020-05-06 2023-03-15 Mars Incorporated Palatable support compositions for administration of medicinal products
JP2023554665A (ja) 2020-12-18 2023-12-28 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド ホウ素含有ピラゾール化合物、それらを含む組成物、それらの方法及び使用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3615728A (en) * 1968-10-11 1971-10-26 Us Agriculture Method for imparting hickory smoke color and flavor to dried yeast and other food powders
GB1261299A (en) * 1969-09-18 1972-01-26 Gen Mills Inc Extruded articles
US3773525A (en) * 1970-08-31 1973-11-20 A Pittet Flavoring with bicyclic dehydropiperazines
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
JP2849844B2 (ja) * 1990-02-21 1999-01-27 アース製薬株式会社 動物用健康飲料
US5180720A (en) * 1991-05-03 1993-01-19 G. D. Searle & Co. 2- and 3-alkoxy or hydroxy-8-substituted-dibenz[b,f]-[1,4]oxazepine-10(11H)-carboxylic acid, substituted hydrazides and methods for treating pain
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
CA2103443C (en) * 1991-05-28 1998-12-22 Robert P. Geyer Chewable drug-delivery composition
US5296209A (en) 1992-01-17 1994-03-22 Colgate Palmolive Company Pet chew product having oral care properties
US5477815A (en) * 1992-08-20 1995-12-26 Booda Products, Inc. Dog chew toy
JPH07115917A (ja) * 1993-10-27 1995-05-09 Minaminihon Rakunou Kyodo Kk ペット用飼料及びその製造方法
EP0745036B1 (en) * 1994-02-16 1998-03-25 Bettacare Limited Infant car seats
US5894029A (en) * 1994-03-21 1999-04-13 Purebred Pet Products, Inc. Method of making pet snack food
AUPM969994A0 (en) * 1994-11-28 1994-12-22 Virbac S.A. Equine anthelmintic formulations
US5637313A (en) * 1994-12-16 1997-06-10 Watson Laboratories, Inc. Chewable dosage forms
US5962499A (en) * 1995-03-20 1999-10-05 Merck & Co., Inc. Nodulisporic acid derivatives
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
ZA964928B (en) * 1995-06-13 1997-12-10 American Home Prod Oral formulations of S(+)-etodolac.
JPH0928312A (ja) * 1995-07-17 1997-02-04 Earth Chem Corp Ltd 動物用食餌材
US6645988B2 (en) * 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions
US5673653A (en) * 1996-09-26 1997-10-07 Sherrill; Les R. Chew toys for domestic carnivorous animals and method for making same
US6126978A (en) * 1996-10-25 2000-10-03 T.F.H. Publications, Inc. Edible dog chew
US6110521A (en) * 1996-10-25 2000-08-29 T.F.H. Publications, Inc. Wheat and casein dog chew with modifiable texture
US5827565A (en) * 1996-10-25 1998-10-27 T.F.H. Publications, Inc. Process for making an edible dog chew
US6086940A (en) * 1996-10-25 2000-07-11 T.F.H. Publications, Inc. High starch content dog chew
US6200616B1 (en) * 1996-10-25 2001-03-13 Tfh Publications, Inc. Animal chew
US6093427A (en) * 1997-09-03 2000-07-25 T.F.H.Publications, Inc. Vegetable-based dog chew
WO1998054296A1 (en) * 1997-05-28 1998-12-03 Chiron S.P.A. Culture medium with yeast or soy bean extract as aminoacid source and no protein complexes of animal origin
US6146679A (en) * 1997-10-03 2000-11-14 Koala Property Limited Method of manufacturing an expanded, extruded food product
US5904937A (en) * 1997-10-03 1999-05-18 Fmc Corporation Taste masked pharmaceutical compositions
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US6093441A (en) * 1998-07-15 2000-07-25 Tfh Publications, Inc. Heat modifiable peanut dog chew
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
US6387381B2 (en) 1998-09-24 2002-05-14 Ez-Med Company Semi-moist oral delivery system
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
US6159516A (en) * 1999-01-08 2000-12-12 Tfh Publication, Inc. Method of molding edible starch
US6210709B1 (en) * 1999-03-24 2001-04-03 Elementis Specialties, Inc. Flexible gelatin free encapsulation material useful for pharmaceuticals, paint balls and other formulations
JP2001136914A (ja) * 1999-08-30 2001-05-22 Earth Chem Corp Ltd ペットフード
US6274182B1 (en) * 1999-11-19 2001-08-14 Tfh Publications, Inc. Animal chew
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US6207179B1 (en) * 2000-05-18 2001-03-27 Phoenix Scientific, Inc. Parasiticidal formulation for animals and a method of making this formulation
JP2002065098A (ja) * 2000-09-04 2002-03-05 Iris Ohyama Inc 食餌材
EP1247456A3 (en) * 2001-02-28 2003-12-10 Pfizer Products Inc. Palatable pharmaceutical compositions for companion animals
US20030064941A1 (en) * 2001-05-21 2003-04-03 Pfizer Inc. Avermectin and praziquantel combination therapy
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
WO2004014143A1 (en) * 2002-08-13 2004-02-19 Akzo Nobel Compositions and process for delivering an additive

Also Published As

Publication number Publication date
CY1117477T1 (el) 2017-04-26
EP1539116A4 (en) 2011-03-02
SI1539116T1 (sl) 2016-06-30
WO2004016252A1 (en) 2004-02-26
EP1539116A1 (en) 2005-06-15
BR0313528A (pt) 2005-06-21
MXPA05001825A (es) 2005-05-27
CR7742A (es) 2005-06-15
AU2009233654A1 (en) 2009-11-26
JP2006502140A (ja) 2006-01-19
HUE029071T2 (en) 2017-01-30
KR20050053619A (ko) 2005-06-08
EP1539116B1 (en) 2016-02-17
DK1539116T3 (en) 2016-03-21
AU2009233654B2 (en) 2011-07-07
CN1681482B (zh) 2012-10-17
AU2003258224A1 (en) 2004-03-03
CR10271A (es) 2008-09-30
CN1681482A (zh) 2005-10-12
HK1071705A1 (zh) 2005-07-29
BR0313528B1 (pt) 2014-10-21
US20040037869A1 (en) 2004-02-26
NZ538333A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
ES2571828T3 (es) Formulaciones veterinarias que no contienen productos de origen animal
CR8480A (es) Formulaciones veterinarias que contienen producto no animal
JP2016175936A5 (es)
AR055363A1 (es) Formulaciones farmaceuticas que comprenden un beta 2- agonista de accion prolongada para administracion por nebulizacion
PL335571A1 (en) Stabilisation of acid-sensitive benzimidazoles by combining them with amino acids and cyclodextrins
JP5824739B2 (ja) 爪障害の治療のための局所殺菌剤
HUT62460A (en) Process for producing veterinary composition with delayed release of active ingredient, orally administrable to ruminants
BR0013010B1 (pt) Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
MX2007014768A (es) Composiciones concentradas de alta carga utiles para el control de ecto y endo parasitos.
MXPA05005046A (es) Formulaciones parasiticidas topicas y metodos de tratamiento.
AR024564A1 (es) Composicion que comprende esfingomielinasa para el uso como una preparacion dietetica, suplemento dietario o producto farmaceutico
ECSP034915A (es) Formulacion farmaceutica de sabor enmascarado y procedimiento para su preparacion
PE20010859A1 (es) Productos de papel tisu que contienen agentes antivirales que son suaves a la piel
RU2216549C2 (ru) Пиперазин-циклодекстриновый комплекс и лекарственное средство, содержащее указанный комплекс
PA8459201A1 (es) Composicion farmaceutica antimastitica a base de extractos de origen natural y procedimiento para fabricarla
Dayrit et al. The Potential of Coconut Oil as an Effective and Safe Antiviral Agent Against the Novel Coronavirus (nCoV-2019)
ATE454151T1 (de) Arzneimittel für nicht-cardiogene diastolische dysfunktion
WO2009103901A3 (fr) Composition pharmaceutique contenant un derive de n-phenylpyrazole et du glycofurol, utilisation pour la preparation d'un medicament veterinaire topique pour lutter contre les puces
WO2009087286A3 (fr) Utilisation d'un derive de 1-n-(halo-3-pyridylmethyle)-n- methylamino-1-alkylamino-2-nitroethylene pour la preparation d'une composition pharmaceutique veterinaire topique pour lutter contre les parasites externes
DE60006551D1 (de) Waessriges konservierungs- bzw. saeuerungsmittel
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
WO2009017383A3 (en) Sustained-release formulation comprising metformin acid salt
KR101553334B1 (ko) 알파 리포산염 수용액의 제조방법 및 이의 용도
AR062674A1 (es) Formulacion acuosa que comprende un agente antitumoral
Ampode Plant secondary compounds as an alternative anthelmintic in mitigating gastrointestinal nematodes in ruminants: a review